https://www.avient.com/knowledge-base/article/can-polyketone-pk-materials-provide-alternative-polyoxymethylene-pom
Download this free study to determine if PK can address POM’s toxicity and sustainability issues without sacrificing performance.
https://www.avient.com/knowledge-base/article/overmolding-mold-design?rtype[]=1164
In general, the rough surface produced when EDM the cavity will produce a good surface and good release from the mold.
Higher hardness and filled grades usually have lower ultimate elongation and therefore are more easily degated.
https://www.avient.com/sites/default/files/2021-07/fl.datasheet-wireharnessyarn.pdf
FL.Datasheet WireHarnessYarn.indd FIBER OPTICAL CABLES MOVING HIGH PERFORMANCE FIBERS FORWARD Key Features • Available flat, twisted, or cord • Reduction in overall weight & energy usage • High temperature resistance • Protection from thermal degradation • Various colors available for easy identification • Abrasion resistant FIBER-LINE® FIBERS FOR WIRE HARNESS YARN • Kevlar® Para-Aramid • Nomex® Meta-Aramid • Technora® Para-Aramid • PET Polyester FIBER-LINE® PERFORMANCE ADDING COATINGS • FIBER-LINE® Colorcoat™: Color Identification • FIBER-LINE® Wearcoat™: Abrasion & High-Temperature Resistance • FIBER-LINE® Bondcoat™: Adhesion & Bonding • FIBER-LINE® Flamecoat™: Flame retardancy Overview • FIBER-LINE® provides a wide range of products utilized for wire harnesses.
No freedom from any patents or other industrial or intellectual property rights is granted or to be inferred.
https://www.avient.com/news/archives?page=34
Avient To Add Further Capacity For Medical-Grade Mevopur™ Materials in Asia Pacific
Avient Announces Second Quarter 2025 Results...
Avient Announces Quarterly Dividend...
https://www.avient.com/news/polyone-showcases-continuous-fiber-composite-materials-camx-2018
Avient Announces Second Quarter 2025 Results...
Avient Announces Quarterly Dividend...
Avient To Hold Second Quarter 2025 Conference Call...
https://www.avient.com/sites/default/files/2025-05/AVNT May Investor Presentation_w_non-GAAP_0.pdf
Solutions from across 3.
Play bigger and bolder in high growth markets and portfolios supported by secular trends to create product platforms of scale 2.
Moving up the value chain, and expanding addressable market size by providing materials solutions in select and prioritized areas Copyright © .
https://www.avient.com/sites/default/files/resources/POL%2520IR%2520Presentation%2520-%2520Goldman%2520Sachs%2520Conference%2520w%2520nonGAAP.pdf
They are based on management’s expectations that involve a number of business risks and uncertainties, any of which could cause actual results to differ materially from those expressed in or implied by the forward-looking statements.
S&P 500 -150% -50% 50% 150% 250% 350% 450% 550% POL S&P 500 All time high of $43.34 July 1st, 2014 PolyOne Corporation Page 9 2006 2014 YTD 2015 “Where we were” “Where we are” Target 1) Operating Income % Specialty: Global Color, Additives & Inks 1.7% 14.9% 12 – 16% Global Specialty Engineered Materials 1.1% 12.1% 12 – 16% Designed Structures & Solutions -- 7.6% 8 – 10% Performance Products & Solutions 5.5% 8.1% 9 – 12% Distribution 2.6% 6.2% 6 – 7.5% 2) Specialty Platform % of Operating Income 6.0% 65% 65 – 75% 3) ROIC* 5.0% 10.6% 15% 4) Adjusted EPS Growth N/A 37% Double Digit Expansion Proof of Performance & 2015 Goals *ROIC is defined as TTM adjusted OI divided by the sum of average debt and equity over a 5 quarter period PolyOne Corporation Page 10 32% Adjusted EPS CAGR from 2011 2015 EPS: $2.50 2011 EPS: $0.82 Continued Gross Margin Expansion Mergers & Acquisitions Spartech Accretion Incremental Share Buybacks Ongoing LSS Programs (50-100 bps/yr) Accelerated Innovation & Mix Improvement Several Levers to Drive Growth Mid Single Digit Revenue Growth PolyOne Corporation Page 11 Innovation Drives Earnings Growth *Percentage of Specialty Platform revenue from products introduced in last five years $20 $53 2006 2013 Research & Development Spending ($ millions) Specialty Platform Vitality Index Progression* 14% 31% 2006 2013 Specialty Platform Gross Margin % 20% 43% 2006 2013 Specialty Vitality Index Target ≥ 35% Vitality Products + 700 to 1000 bps PolyOne Corporation Page 12 Prototype Frame Opportunity Scale-up & Test Market Build Business Case Commercial Launch Phase 1 Phase 2 Phase 3 Phase 4 Phase 5 4 11 5 10 6 9 3 4 2 15 9 1 10 4 Breakthrough Platform Derivative A Rich Pipeline of Opportunity Number of Projects 25 14 19 17 18 93 Addressable Market ($ millions) TBD TBD $800 $450 $450 $1,700 PolyOne Corporation Page 13 Megatrends Aligned with Key End Markets Decreasing Dependence on Fossil Fuels Protecting the Environment Improving Health and Wellness Megatrend End Markets Globalizing and Localizing Health & Wellness Transportation Packaging Consumer PolyOne Corporation Page 14 60% 100% 20% 30% 40% 50% 60% 70% 80% 90% 100% 2008 2014 Pension Funding** As of September 30, 2014 Debt Maturities & Pension Funding – 9/30/14 Net Debt / EBITDA* = 1.7x $48 $317 $600 $0 $100 $200 $300 $400 $500 $600 $700 $800 2015 2020 2023 Debt Maturities As of September 30, 2014 ($ millions) Coupon Rates: 7.500% 7.375% 5.250% ** includes US-qualified pension plans only *TTM 9/30/2014 PolyOne Corporation Page 15 Free Cash Flow and Strong Balance Sheet Fund Investment / Shareholder Return Expanding our sales, marketing, and technical capabilities Targets that expand our: • Specialty offerings • End market presence • Geographic footprint • Operating Margin Synergy opportunities Adjacent material solutions Repurchased 1.5 million shares in Q3 2014 Repurchased 9.7 million shares since early 2013 10.3 million shares are available for repurchase under the current authorization Organic Growth Acquisitions Share Repurchases Dividends Investing in operational and LSS initiatives (including synergy capture) Manufacturing alignment $0.16 $0.20 $0.24 $0.32 $0.40 $0.10 $0.20 $0.30 $0.40 $0.50 2011 2012 2013 2014 2015 Annual Dividend PolyOne Corporation Page 16 PolyOne Core Values Innovation Collaboration Excellence PolyOne Corporation Page 17 The New PolyOne: A Specialty Growth Company Why Invest In PolyOne?
��PolyOne Investor Presentation�Goldman Sachs 2014 US Emerging / SMID Cap Growth Conference�New York, NY�November 20, 2014�� Forward-Looking Statements Use of Non-GAAP Measures PolyOne Commodity to Specialty Transformation PolyOne�At A Glance Mix Shift Highlights Specialty Transformation Confirmation of Our Strategy Strategy and Execution Drive Results Proof of Performance & 2015 Goals 32% Adjusted EPS CAGR from 2011 Innovation Drives Earnings Growth A Rich Pipeline of Opportunity Megatrends Aligned with Key End Markets Debt Maturities & Pension Funding – 9/30/14 Free Cash Flow and Strong Balance Sheet �Fund Investment / Shareholder Return PolyOne Core Values Why Invest In PolyOne?
https://www.avient.com/sites/default/files/2020-07/avient-abac-english-200720.pdf
Associates should never offer or accept anything HOME | TOC 3 of value to/from existing or potential customers, suppliers or other third parties in order to improperly obtain business or an unfair advantage for Avient.
Kickbacks are typically negotiated amounts extracted from the payment of goods and returned to the bribe-taker.
Avient does not offer or accept facilitation payments or kickbacks of any kind to or from government officials, customers, vendors, or other business partners.
https://www.avient.com/resources/safety-data-sheets?page=6201
050GN2057 GREEN XLPE
Milled-Food Grade MSC Dispersion
To search using the product code please remove the last two characters from the code for your search.
https://www.avient.com/sites/default/files/2021-04/trilliant-hc-conductive-pipette-case-study.pdf
CONDUCTIVE PIPETTE TIP MANUFACTURER ACHIEVES SIGNIFICANT SAVINGS © 2021, All Rights Reserved Avient Corporation, 33587 Walker Road, Avon Lake, Ohio USA 44012 To learn more about Trilliant™ HC, contact Avient at +1.844.4AVIENT (1.844.428.4368) or visit us at avient.com.
THE CHALLENGE A manufacturer of high-quality laboratory research products was eager to expand into the conductive pipette tip market.
Through customer intimacy, Avient’s Trilliant HC formulations offered an effective solution that allowed the manufacturer to improve its bottom line and increase its operating income.